MA
AGN

MCF Advisors’s Allergan plc AGN Stock Holding History

MCF Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$15K – 486
2019
Q1 		$15K Hold
100
– – ﹤0.01% 326
2018
Q4 		$13K Hold
100
– – ﹤0.01% 334
2018
Q3 		$19K Hold
100
– – ﹤0.01% 304
2018
Q2 		$17K Hold
100
– – ﹤0.01% 297
2018
Q1 		$17K Sell
100
-100
-50% -$16.8K ﹤0.01% 302
2017
Q4 		$33K Hold
200
– – 0.01% 260
2017
Q3 		$41K Hold
200
– – 0.01% 250
2017
Q2 		$49K Hold
200
– – 0.01% 227
2017
Q1 		$48K Hold
200
– – 0.01% 236
2016
Q4 		$42K Hold
200
– – 0.01% 220
2016
Q3 		$46K Hold
200
– – 0.01% 212
2016
Q2 		$46K Buy
+200
New +$46.1K 0.01% 230

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MCF Advisors's AGN Position: Q2 2019 in Review

MCF Advisors sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 100 shares — an estimated $15K sold.

MCF Advisors first reported a position in AGN in Q2 2016 and held it in 12 quarters. The position peaked at $49K in Q2 2017. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • MCF Advisors reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • MCF Advisors sold 100 Allergan plc shares in Q2 2019, an estimated $15K.
  • MCF Advisors first reported a position in Allergan plc in Q2 2016 and held it in 12 quarters.
  • MCF Advisors's Allergan plc position peaked at $49K in Q2 2017.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on MCF Advisors's 13F filing for Q2 2019, filed 6 Aug 2019.